These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 214512)

  • 61. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.
    Zinkernagel RM; Althage A; Cooper S; Kreeb G; Klein PA; Sefton B; Flaherty L; Stimpfling J; Shreffler D; Klein J
    J Exp Med; 1978 Aug; 148(2):592-606. PubMed ID: 212503
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A T helper cell for anti-viral cytotoxic T-cell responses.
    Ashman RB; Müllbacher A
    J Exp Med; 1979 Nov; 150(5):1277-82. PubMed ID: 227982
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice.
    Kievits F; Lokhorst W; Ivanyi P
    Eur J Immunol; 1990 May; 20(5):1189-92. PubMed ID: 1694133
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T cell recognition of the immunodominant Sendai virus NP324-332/Kb epitope is focused on the center of the peptide.
    Cole GA; Hogg TL; Woodland DL
    J Immunol; 1995 Sep; 155(6):2841-8. PubMed ID: 7673700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes.
    Braciale TJ; Andrew ME; Braciale VL
    J Exp Med; 1981 Apr; 153(4):910-23. PubMed ID: 6166708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Active component of HVJ (sendai virus) for interferon on induction in mice.
    Ito Y; Nishiyama Y; Shimokata K; Takeyama H; Kunii A
    Nature; 1978 Aug; 274(5673):801-2. PubMed ID: 210393
    [No Abstract]   [Full Text] [Related]  

  • 69. Specific adsorption of H-2-restricted cytotoxi T cells to macrophage monolayers.
    Kees U; Müllbacher A; Blanden RV
    J Exp Med; 1978 Dec; 148(6):1711-5. PubMed ID: 214513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. H-2Kk and vesicular stomatitis virus G proteins are not extensively associated in reconstituted membranes recognized by T cells.
    Cartwright GS; Smith LM; Heinzelmann EW; Ruebush MJ; Parce JW; McConnell HM
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1506-10. PubMed ID: 6280187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
    Kast WM; Roux L; Curren J; Blom HJ; Voordouw AC; Meloen RH; Kolakofsky D; Melief CJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2283-7. PubMed ID: 1848698
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of Sendai virion envelope and a mouse surface membrane polypeptide on newly infected cells: lack of association with H-2K/D or alteration of viral immunogenicity.
    Zarling DA; Miskimen JA; Fan DP; Fujimoto EK; Smith PK
    J Immunol; 1982 Jan; 128(1):251-7. PubMed ID: 6274956
    [No Abstract]   [Full Text] [Related]  

  • 73. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
    Schrader JW; Edelman GM
    J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes.
    Braciale TJ; Andrew ME; Braciale VL
    J Exp Med; 1981 May; 153(5):1371-6. PubMed ID: 6166717
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alloantigen bound to agarose beads and syngeneic carrier cells are capable of stimulating mouse cytolytic T lymphocytes in vitro.
    Fast LD; Fan DP
    J Immunol; 1979 Oct; 123(4):1491-6. PubMed ID: 90085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions.
    Geiger B; Rosenthal KL; Klein J; Zinkernagel RM; Singer SJ
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4603-7. PubMed ID: 228303
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculation.
    Kibler R; Solvay MJ; ter Meulen V
    Exp Cell Biol; 1978; 46(1-2):11-30. PubMed ID: 202521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen.
    Weinberger O; Herrmann SH; Mescher MF; Benacerraf B; Burakoff SJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6091-5. PubMed ID: 6969401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.
    Plata F
    J Exp Med; 1982 Apr; 155(4):1050-62. PubMed ID: 6174669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.